A meta-analysis of extracorporeal shock wave therapy for Peyronie’s disease – (International Journal of Impotence Research 2016) – Peyronie’s disease (PD) is a relatively common disorder originating from connective tissue and characterized by progressively fibrotic plaques in the penile tunica albuginea. Click here to read full article about shockwave therapy for Peyronie’s disease.Read More
International Study for the Study of Women’s Sexual Health ISSWSH Annual Meeting 2020 Preliminary Scientific Program Retrospective Chart Review of Treatment Outcome Following Low-Intensity Shockwave Therapy for the Treatment of Vestibulodynia with Urogold 100tm MTS Click here to read full article from the International Study for the Study of Women’s Sexual Health.Read More
Currently, there are no effective therapy strategies for idiopathic, non-organic vulvodynia in women. ESWT (extracorporeal shock wave therapy) is a nonsurgical/noninvasive technique widely used to treat musculoskeletal diseases, muscle spasticity and hypertonia, renal and biliary calculi and urological disorders. Click here to read more.Read More
Erectile dysfunction is highly prevalent in type II diabetes mellitus.Low intensity extracorporeal shock wave therapy improves erectile function inpatients with erectile dysfunction of vasculogenic origin, including diabetes.However, its mode of action remains unknown. We investigated the effects of low intensity extracorporeal shock wave therapy compared to or combined with sildenafil on erectile dysfunction in a...Read More
A review of preclinical studies – Low-intensity extracorporeal shock wave therapy (LI-ESWT) is a novel treatment for erectile dysfunction (ED). Its ability to improve erectile function has been shown in patients with vasculogenic ED by many randomized-controlled trials againsts ham procedures. However, the role of LI-ESWT in ED caused by radical prostatectomy (RP) is still questionable...Read More
